Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin
- 18 June 1994
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 343 (8912), 1554-1555
- https://doi.org/10.1016/s0140-6736(94)92945-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Comparative Study of the Efficacy and Tolerability of Simvastatin and Pravastatin in Patients with Primary HypercholesterolaemiaClinical Drug Investigation, 1993
- Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemiaThe American Journal of Cardiology, 1993
- A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemiaThe American Journal of Cardiology, 1993
- Comparative hypolipidemic effects of lovastatin and simvastatin in patients with heterozygous familial hypercholesterolemiaAtherosclerosis, 1992
- Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.BMJ, 1992
- Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemiaArchives of Internal Medicine, 1991
- Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levelsJournal of Internal Medicine, 1990
- Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1987
- EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1986
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1984